Experienced in Calcium Pyrophosphate Arthritis

Dr. Richard Roseff

Rheumatology
Healthnomic Partners/Sagebrush Health
105 Newtown Rd, 
Danbury, CT 
Experienced in Calcium Pyrophosphate Arthritis
Healthnomic Partners/Sagebrush Health
105 Newtown Rd, 
Danbury, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Roseff is a Rheumatologist in Danbury, Connecticut. Dr. Roseff is rated as an Experienced provider by MediFind in the treatment of Calcium Pyrophosphate Arthritis. His top areas of expertise are Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis, Rheumatoid Pneumoconiosis, and Rheumatoid Lung Disease.

His clinical research consists of participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in CT
Hospital Affiliations
Danbury Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Healthnomic Partners/Sagebrush Health
105 Newtown Rd, Danbury, CT 06810
Call: 203-743-9596

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials
Similar Doctors
Distinguished in Calcium Pyrophosphate Arthritis
Dr. Leslie D. Kerr
Rheumatology
Distinguished in Calcium Pyrophosphate Arthritis
Dr. Leslie D. Kerr
Rheumatology

Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Place, Rheumatology Division Of M, 
New York, NY 
 (79.3 miles away)
212-987-3100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leslie Kerr is a Rheumatologist in New York, New York. Dr. Kerr is rated as a Distinguished provider by MediFind in the treatment of Calcium Pyrophosphate Arthritis. Her top areas of expertise are Calcium Pyrophosphate Arthritis, Juvenile Temporal Arteritis, Giant Cell Arteritis (GCA), and Temporal Arteritis.

Distinguished in Calcium Pyrophosphate Arthritis
Dr. Timothy E. Quan
Rheumatology
Distinguished in Calcium Pyrophosphate Arthritis
Dr. Timothy E. Quan
Rheumatology

Rheumatology Specialists Of Connecticut Inc

399 Farmington Ave, Suite Ll2, 
Farmington, CT 
 (9.0 miles away)
860-432-8400
Languages Spoken:
English
See accepted insurances

Timothy Quan is a Rheumatologist in Farmington, Connecticut. Dr. Quan is rated as a Distinguished provider by MediFind in the treatment of Calcium Pyrophosphate Arthritis. His top areas of expertise are Rhizomelic Pseudopolyarthritis, Chondrocalcinosis 2, Polymyalgia Rheumatica, and Rheumatoid Arthritis (RA).

Advanced in Calcium Pyrophosphate Arthritis
Dr. Stuart N. Novack
Rheumatology
Advanced in Calcium Pyrophosphate Arthritis
Dr. Stuart N. Novack
Rheumatology

Nuvance Health Medical Practice Ct Inc

761 Main Ave, 
Norwalk, CT 
 (41.7 miles away)
203-403-3490
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stuart Novack is a Rheumatologist in Norwalk, Connecticut. Dr. Novack is rated as an Advanced provider by MediFind in the treatment of Calcium Pyrophosphate Arthritis. His top areas of expertise are Chondrocalcinosis 2, Calcium Pyrophosphate Arthritis, Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica.

VIEW MORE CALCIUM PYROPHOSPHATE ARTHRITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roseff's expertise for a condition
ConditionClose
    • Distinguished
    • Axial Spondyloarthritis (AxSpA)
      Dr. Roseff is
      Distinguished
      . Learn about Axial Spondyloarthritis (AxSpA).
      See more Axial Spondyloarthritis (AxSpA) experts
    • Advanced
    • Ankylosing Spondylitis
      Dr. Roseff is
      Advanced
      . Learn about Ankylosing Spondylitis.
      See more Ankylosing Spondylitis experts
    • Fibromyalgia
      Dr. Roseff is
      Advanced
      . Learn about Fibromyalgia.
      See more Fibromyalgia experts
    • Gout
      Dr. Roseff is
      Advanced
      . Learn about Gout.
      See more Gout experts
    • Lyme Disease
      Dr. Roseff is
      Advanced
      . Learn about Lyme Disease.
      See more Lyme Disease experts
    • Melorheostosis
      Dr. Roseff is
      Advanced
      . Learn about Melorheostosis.
      See more Melorheostosis experts
    • Melorheostosis with Osteopoikilosis
      Dr. Roseff is
      Advanced
      . Learn about Melorheostosis with Osteopoikilosis.
      See more Melorheostosis with Osteopoikilosis experts
    View All 18 Advanced Conditions
    • Experienced
    • Arthritis
      Dr. Roseff is
      Experienced
      . Learn about Arthritis.
      See more Arthritis experts
    • Behcet Disease
      Dr. Roseff is
      Experienced
      . Learn about Behcet Disease.
      See more Behcet Disease experts
    • Bursitis
      Dr. Roseff is
      Experienced
      . Learn about Bursitis.
      See more Bursitis experts
    • Calcium Pyrophosphate Arthritis
      Dr. Roseff is
      Experienced
      . Learn about Calcium Pyrophosphate Arthritis.
      See more Calcium Pyrophosphate Arthritis experts
    • Giant Cell Arteritis (GCA)
      Dr. Roseff is
      Experienced
      . Learn about Giant Cell Arteritis (GCA).
      See more Giant Cell Arteritis (GCA) experts
    • IgG4-Related Disease
      Dr. Roseff is
      Experienced
      . Learn about IgG4-Related Disease.
      See more IgG4-Related Disease experts
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved

      Request a Doctor Appointment

      Please fill out the details in the form below to allow MediFind to submit an appointment request to Dr. Richard Roseff's office on your behalf. Your provider may contact you directly to complete scheduling. If you are experiencing a medical emergency, please call 9-1-1. This form is for appointment requests only. Currently, we are not accepting appointments from users outside of the US.

          Close
          0 / 1000

          Please provide us with the below insurance information:

          By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.